Home › Multiple Sclerosis › Texas › Houston
Multiple Sclerosis clinical trials in Houston, TX
6 studies for Multiple Sclerosis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Recruiting
- The University of Texas Health Science Center at Houston, Houston
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
RecruitingPhase 3
- Neuro-Eye Clinical Trials, Houston
Care in Multiple Sclerosis (MS)
RecruitingObservational study
- Baylor College of Medicine, Houston
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Recruiting
- Houston Methodist Hospital, Houston
Multiple Sclerosis Implementation Network (Registry)
RecruitingObservational study
- The University of Texas Health Science Center at Houston (UTHealth Houston), Houston
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Seattle, WA7 studies
- Columbus, OH7 studies
- Baltimore, MD7 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.